Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Clint Pecenka

Showing results (81-90 of 98) with videos related to

Pageof 10
Sort By:
The Lancet. Global Health|April 19, 2015
Health gains and financial risk protection afforded by public financing of selected interventions in Ethiopia: an extended cost-effectiveness analysisStéphane Verguet, Zachary D Olson, Joseph B Babigumira, et al.
Human Vaccines & Immunotherapeutics|December 17, 2024
Gathering information on maternal immunization readiness in Bangladesh, Ghana, Kenya, Mozambique, and Nepal: Applying a WHO checklistRanju Baral, Sophia Knudson, Iracema Barros, et al.
Vaccine|February 1, 2025
What will introducing and delivering new maternal vaccines cost in Ghana and Mozambique? A prospective analysisRanju Baral, Kwame Amponsa-Achiano, Iracema Barros, et al.
Vaccines|June 28, 2023
Respiratory Syncytial Virus (RSV) Disease and Prevention Products: Knowledge, Attitudes, and Preferences of Kenyan Healthcare Workers in Two Counties in 2021Bryan O Nyawanda, Victor A Opere, Joyce U Nyiro, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|April 10, 2016
Cost-Effectiveness of Monovalent Rotavirus Vaccination of Infants in Malawi: A Postintroduction Analysis Using Individual Patient-Level Costing DataNaor Bar-Zeev, Jacqueline E Tate, Clint Pecenka, et al.
PLOS Global Public Health|May 5, 2023
Optimizing next-generation RSV prevention in Mali: A cost-effectiveness analysis of pediatric vaccination, maternal vaccination, and extended half-life monoclonal antibody immunoprophylaxisRachel S Laufer, Ranju Baral, Andrea G Buchwald, et al.
BMC Public Health|December 2, 2025
Maternal vaccine delivery costs in South Asian settings: estimates from Bangladesh and NepalRanju Baral, Jessica A Fleming, Abhiyan Gautam, et al.
BMC Public Health|September 4, 2024
The cost of care for children hospitalized with respiratory syncytial virus (RSV) associated lower respiratory infection in KenyaJoyce U Nyiro, Bryan O Nyawanda, Martin Mutunga, et al.
Plos One|January 11, 2021
Costs of continuing RTS,S/ASO1E malaria vaccination in the three malaria vaccine pilot implementation countriesRanju Baral, Ann Levin, Chris Odero, et al.
Vaccine|September 30, 2023
Report of the WHO technical consultation on the evaluation of respiratory syncytial virus prevention cost effectiveness in low- and middle-income countries, April 7-8, 2022Meagan C Fitzpatrick, Rachel S Laufer, Ranju Baral, et al.
Pageof 10

Showing results (81-90 of 98) with videos related to

Sort By:
Pageof 10
The Lancet. Global Health|April 19, 2015
Health gains and financial risk protection afforded by public financing of selected interventions in Ethiopia: an extended cost-effectiveness analysisStéphane Verguet, Zachary D Olson, Joseph B Babigumira, et al.
Human Vaccines & Immunotherapeutics|December 17, 2024
Gathering information on maternal immunization readiness in Bangladesh, Ghana, Kenya, Mozambique, and Nepal: Applying a WHO checklistRanju Baral, Sophia Knudson, Iracema Barros, et al.
Vaccine|February 1, 2025
What will introducing and delivering new maternal vaccines cost in Ghana and Mozambique? A prospective analysisRanju Baral, Kwame Amponsa-Achiano, Iracema Barros, et al.
Vaccines|June 28, 2023
Respiratory Syncytial Virus (RSV) Disease and Prevention Products: Knowledge, Attitudes, and Preferences of Kenyan Healthcare Workers in Two Counties in 2021Bryan O Nyawanda, Victor A Opere, Joyce U Nyiro, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|April 10, 2016
Cost-Effectiveness of Monovalent Rotavirus Vaccination of Infants in Malawi: A Postintroduction Analysis Using Individual Patient-Level Costing DataNaor Bar-Zeev, Jacqueline E Tate, Clint Pecenka, et al.
PLOS Global Public Health|May 5, 2023
Optimizing next-generation RSV prevention in Mali: A cost-effectiveness analysis of pediatric vaccination, maternal vaccination, and extended half-life monoclonal antibody immunoprophylaxisRachel S Laufer, Ranju Baral, Andrea G Buchwald, et al.
BMC Public Health|December 2, 2025
Maternal vaccine delivery costs in South Asian settings: estimates from Bangladesh and NepalRanju Baral, Jessica A Fleming, Abhiyan Gautam, et al.
BMC Public Health|September 4, 2024
The cost of care for children hospitalized with respiratory syncytial virus (RSV) associated lower respiratory infection in KenyaJoyce U Nyiro, Bryan O Nyawanda, Martin Mutunga, et al.
Plos One|January 11, 2021
Costs of continuing RTS,S/ASO1E malaria vaccination in the three malaria vaccine pilot implementation countriesRanju Baral, Ann Levin, Chris Odero, et al.
Vaccine|September 30, 2023
Report of the WHO technical consultation on the evaluation of respiratory syncytial virus prevention cost effectiveness in low- and middle-income countries, April 7-8, 2022Meagan C Fitzpatrick, Rachel S Laufer, Ranju Baral, et al.
Pageof 10